Eli Lilly & Co
LLY· NYSE
Released Oct 29, 2014
10-Q filed Oct 29, 2014, 29 days after period end · 0000059478-14-000169
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $4.88B | $5.77B | $5.44B | $6.15B |
| Net Income | $500.60M | $1.20B | $1.33B | $1.24B |
| EPS Diluted | $0.47 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.11 |
| $1.18 |
| $1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.